James Edgemond, CFO AND TREASURER at UNITED THERAPEUTICS Corp (UTHR), sold 10,000 shares at $544.96 ($5.5M) on 2026-06-01, disclosed to the SEC on 2026-06-02.
Scheduled sale ($5.5M) by CFO AND TREASURER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $544.96 | 1,440 | $785K | 14.3% |
| 2 | $546.23 | 2,520 | $1.4M | 25.1% |
| 3 | $547.11 | 1,354 | $741K | 13.5% |
| 4 | $548.26 | 1,606 | $881K | 16.1% |
| 5 | $549.30 | 1,185 | $651K | 11.9% |
| 6 | $550.20 | 1,015 |
| $558K |
| 10.2% |
| 7 | $550.81 | 200 | $110K | 2.0% |
| 8 | $552.92 | 280 | $155K | 2.8% |
| 9 | $554.47 | 400 | $222K | 4.0% |
| Total | $547.87 avg | 10,000 | $5.5M | 100% |
| Filing → |
| UTHR | SELL | 2026-06-16 | $5.5M | — | Filing → |
| UTHR | SELL | 2026-06-12 | $5.5M | — | Filing → |
| UTHR | SELL | 2026-06-09 | $5.5M | — | Filing → |